Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Toronto Stock Exchange  >  Aphria Inc    APH   CA03765K1049

APHRIA INC (APH)
Mes dernières consult.
Most popular
Report
 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Toronto Stock Exchange
01/15/2018 01/16/2018 01/17/2018 01/18/2018 01/19/2018 Date
21.7 21.65 22.05 21.91 22.19 Last
6464646 9015180 4658857 3542560 2989071 Volume
+20.42% -0.23% +1.85% -0.63% +1.28% Change
Financials ( CAD)
Sales 2018 42,9 M
EBIT 2018 -2,34 M
Net income 2018 26,7 M
Finance 2018 162 M
Yield 2018 -
Sales 2019 211 M
EBIT 2019 60,8 M
Net income 2019 48,1 M
Finance 2019 114 M
Yield 2019 -
P/E ratio 2018 183,75
P/E ratio 2019 71,59
EV / Sales2018 78,6x
EV / Sales2019 16,2x
Capitalization 3 533 M
More Financials
Company
Aphria, Inc. engages in the production and supply of medical marijuana.Its products include alien dawg, champlian indica, grower's blend, champlain-sativa and blueberry.The company was founded by Cole Cacciavillani and John Cervini on June 22, 2011 and is headquartered in Leamington, Canada. ... 
Sector
Pharmaceuticals
Calendar
-
More about the company
Surperformance© ratings of Aphria Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on APHRIA INC
01/03 Canadian pot stocks surge on new U.S. fund, California legalization
01/02 TSX notches record high as resource shares climb
2017 IIROC Trade Resumption - Aphria Inc.
2017 IIROC Trade Halt - Aphria Inc.
2017 Aphria bets C$10 million on Canada's recreational marijuana market
2017 TSX ends lower as banks, mining stocks weigh
2017 APHRIA : Canada's Aphria to sell medical marijuana to Loblaws' pharmacy chain
2017 IIROC Trade Resumption - Aphria Inc.
2017 IIROC Trade Halt - Aphria Inc.
2017 APHRIA : Toronto exchange may delist marijuana firms with U.S. operations
More news
Sector news : Pharmaceuticals - NEC
01:20a At AstraZeneca, fewer drug projects bring big productivity jump
01/18 European shares edge higher as cyclicals back in favour
01/18 ABLYNX : Largest Ablynx investor would consider improved Novo Nordisk bid
01/18 BTG : U.S. court invalidates Johnson & Johnson cancer drug patent, hitting UK's ..
01/17 TSX ends up as banks lead rally after rate hike
More sector news : Pharmaceuticals - NEC
Latest Tweets
01/18Clarus Securities Raises Aphria Q3 2018 Earnings Estimates to $0.02 EPS (Prev.. 
01/18? Cannabis Wheaton: Internationale Versorgungsvereinbarung mit Aphria - Aktie.. 
01/17BRIEF-Cannabis Wheaton Announces International Supply Agreement With Aphria  
01/17#Scythian announces #Aphria as lead investor in $20 million financing
1
01/17BRIEF-Scythian Biosciences Announces Aphria As Lead Investor In $20 Mln Finan.. 
More tweets
Qtime:9
News from SeekingAlpha
01/18 GET OUT YOUR PICKS AND SHOVELS : Ancillary Plays On Cannabis
01/16 2 New Marijuana ETFs Coming
01/15 2018 Is The Year To Make Great Gains In Crypto & Cannabis
01/12 COMPLETE GUIDE TO THE CANNABIS INDUS : Production Capacity
01/11 APHRIA : 62% Revenue Growth
Chart APHRIA INC
Duration : Period :
Aphria Inc Technical Analysis Chart | APH | CA03765K1049 | 4-Traders
Technical analysis trends APHRIA INC
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 8
Average target price 22,0  CAD
Spread / Average Target -0,35%
EPS Revisions
Managers
NameTitle
Victor Neufeld President & Chief Executive Officer
Cole Cacciavillani Chief Operating Officer & Director
Carl A. Merton Chief Financial Officer
John Cervini Director & VP-Infrastructure & Technology
Gary Leong Chief Scientific Officer
Sector and Competitors
1st jan.Capitalization (M$)
APHRIA INC12.76%2 844
JOHNSON & JOHNSON5.11%394 542
NOVARTIS1.02%227 089
PFIZER1.05%218 162
ROCHE HOLDING LTD.-5.33%211 361
MERCK AND COMPANY10.24%169 287